Azopharma Product Development Group

Daniel Cammarata, CPA has joined the company as its chief financial officer. Mr. Cammarata will report to Phil Meeks, chief executive officer and will be responsible for overseeing all financial operations for Azopharma Product Development Group and its subsidiaries. Daniel Cammarata comes to Azopharma with a healthcare services background and was chief financial officer for both AllianceCare and Interim Healthcare.

“We are very excited to have a professional of Dan’s caliber join our organization. He brings years of experience as CFO for growing companies such as ours and will provide leadership to continue managing that growth,” commented Mr. Meeks. “Additionally, Dan has a strong track record of decreasing costs and streamlining business systems. In light of the current economic environment these talents are invaluable.”

Mr. Cammarata said, “I am very excited about joining Azopharma. This company has a strong track record for growth and customer service. I am looking forward to being a part of such a strong team.” Prior to entering the healthcare industry, Mr. Cammarata worked with several leading telecommunication, retail and financial services firms.